Abstract With the improvement of computational resources and development of artificial intelligence, current digital twins (DT) can achieve the integration of multi-omics data via hybrid mechanism- and data-driven models, thereby enabling personalized simulation of patients, organs, and cells. This makes the application of DT in drug evaluation and drug repurposing discovery possible. However, in the rapidly developing situation, practical and regulatory issues have also emerged.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yimin
Contact Yimin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack